Literature DB >> 10703134

The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

J T Flynn1, G Woodruff, J R Thompson, F Hiscox, W Feuer, J Schiffman, A Corona, L K Smith.   

Abstract

CONTEXT: We previously presented the results of an original pooled data set of 961 amblyopic patients who underwent patching therapy for amblyopia from 1965 to 1994 (study group 1). Three types of amblyopia were considered: anisometropic, anisometropic-strabismic, and strabismic. Analysis of this group's success was related to the age at which therapy was initiated, the type of amblyopia, and the depth of visual loss before treatment was begun. The purpose of the current study is to test the validity of these findings on a second group of 961 amblyopes employing the data set used by Woodruff and associates in their publications (study group 2). These 2 data sets, after adjustment to conform to the definitions of age, amblyopia, anisometropia, and similar items utilized in common between the 2 study groups, will be compared for the risk factors predictive of successful occlusion therapy. OUTCOME: As in the previous study, the success of occlusion therapy is defined as a visual acuity of 20/40 or better at the end of treatment.
RESULTS: Success by the 20/40 criteria was achieved in 73.7% in study group 1 and in 59.9% in study group 2. By category, the rate of success in study group 1 was 77.2% in strabismic amblyopia, 67.2% in anisometropic-strabismic amblyopia, and 66.0% in anisometropic amblyopia. In study group 2, success was 61.2% in strabismic amblyopia, 51.2% in anisometropic-strabismic amblyopia, and 63.0% in anisometropic amblyopia. Study group 1 univariate analysis related success in each group to the age at which therapy was initiated, the type of amblyopia, and the depth of visual loss before treatment in each group. In study group 2, univariate analysis related success of occlusion therapy to age and the depth of visual loss before treatment. Type of amblyopia was not related to outcome success in this group. When the 2 data sets were pooled, the risk factors for success were age and depth of visual loss at onset of treatment.
CONCLUSIONS: Factors that appeared closely related to a successful outcome of patching therapy were patient age and depth of visual loss before treatment. These conclusions further support the value of early detection and screening for amblyopia, its prevention, where possible, and its adequate and vigorous treatment when it is detected and diagnosed.

Entities:  

Mesh:

Year:  1999        PMID: 10703134      PMCID: PMC1298270     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  28 in total

1.  Visual impairment in a rural Appalachian community. Prevalence and causes.

Authors:  M R Dana; J M Tielsch; C Enger; E Joyce; J M Santoli; H R Taylor
Journal:  JAMA       Date:  1990-11-14       Impact factor: 56.272

2.  Results in the treatment of anisometropic amblyopia.

Authors:  M Sullivan
Journal:  Am Orthopt J       Date:  1976

3.  Anisometropic amblyopia and its treatment.

Authors:  E M Hedgpeth; M Sullivan
Journal:  South Med J       Date:  1977-09       Impact factor: 0.954

4.  Effect of occlusion treatment for amblyopia at various ages.

Authors:  A M Gokhale; S A Gokhale
Journal:  J All India Ophthalmol Soc       Date:  1969-12

5.  Amblyopic occlusion: the results of treatment.

Authors:  G V Catford
Journal:  Trans Ophthalmol Soc U K       Date:  1967

6.  Prognostic value of laser interferometric visual acuity in amblyopia therapy.

Authors:  A Selenow; K J Ciuffreda; R Mozlin; D Rumpf
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-02       Impact factor: 4.799

7.  Success rate in the treatment of amblyopia by conventional methods.

Authors:  T C Jenkins; L D Pickwell
Journal:  Ophthalmic Physiol Opt       Date:  1982       Impact factor: 3.117

8.  When is it safe to stop patching?

Authors:  J G Oster; J W Simon; P Jenkins
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

9.  Esotropic children with amblyopia: effects of patching on acuity.

Authors:  A B Fulton; D L Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

10.  Practical management of amblyopia.

Authors:  F C Ching; M M Parks; D S Friendly
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1986 Jan-Feb       Impact factor: 1.402

View more
  23 in total

1.  Differences in the management of amblyopia between European countries.

Authors:  J H Y Tan; J R Thompson; I Gottlob
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Amblyopia therapy.

Authors:  B W Fleck
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study.

Authors:  C Williams; K Northstone; R A Harrad; J M Sparrow; I Harvey
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  Electronic recording of occlusion treatment for amblyopia: potential of the new technology.

Authors:  Yaroslava Chopovska; Sjoukje E Loudon; Licia Cirina; Alina Zubcov; Huibert J Simonsz; Marc Lüchtenberg; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

Review 5.  Diagnostic accuracy of vision screening tests for the detection of amblyopia and its risk factors: a systematic review.

Authors:  Christine Schmucker; Robert Grosselfinger; Rob Riemsma; Gerd Antes; Stefan Lange; Wolf Lagrèze; Jos Kleijnen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

6.  The prevalence of amblyopia in Germany: data from the prospective, population-based Gutenberg Health Study.

Authors:  Heike M Elflein; Susanne Fresenius; Julia Lamparter; Susanne Pitz; Norbert Pfeiffer; Harald Binder; Philipp Wild; Alireza Mirshahi
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

7.  Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study.

Authors:  M Dixon-Woods; M Awan; I Gottlob
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

8.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

9.  A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.

Authors:  Michael X Repka; Raymond T Kraker; Roy W Beck; Jonathan M Holmes; Susan A Cotter; Eileen E Birch; William F Astle; Danielle L Chandler; Joost Felius; Robert W Arnold; D Robbins Tien; Stephen R Glaser
Journal:  Arch Ophthalmol       Date:  2008-08

Review 10.  Effectiveness of screening preschool children for amblyopia: a systematic review.

Authors:  Christine Schmucker; Robert Grosselfinger; Rob Riemsma; Gerd Antes; Stefan Lange; Wolf Lagrèze; Jos Kleijnen
Journal:  BMC Ophthalmol       Date:  2009-07-16       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.